He is currently director of the Comprehensive Epilepsy Center. Dr. Bell is a member of the American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiologic Society, and the American Epilepsy Society where is on the Epilepsy and Employment Task Force. He is also a member of the American Association for the Advancement of Science, the Christian Medical and Dental Society and is a fellow of the American College of Physicians. His research interests include localization of seizure foci using ictal semiology, comparative neuroimaging in epilepsy surgery candidates, gene expression in human epileptic tissue and more recently assessment of the utility of antibodies to AMPA receptors in the evaluation of epilepsy patients. He has also participated in numerous clinical drug trials for the treatment of epilepsy.
Neologistic speech automatisms during complex partial seizures.
Reduced bioavailability of moisture-exposed carbamazepine resulting in status epilepticus. Raroque HG, Batjer H, White C, Bell WL, Bowman G, Greenlee R. Lower brain-stem origin of the median nerve N18 potential. Connelly CS, O'Donovan CA, McCall WV, Bell WL, Quinlivan L. Electrocerebral inactivity associated with obstructive sleep apnea. Painful generalised clonic and tonic-clonic seizures with retained consciousness. Changes in glutamate receptor subunit composition in hippocampus and cortex of patients with refractory epilepsy.